Non-executive director Guo Huaqing increases holdings of SciClone Pharmaceuticals-B (02171.HK) by 36,500 shares at a price of 17.29 Hong Kong dollars per share.

According to the Wisdom Financial APP, the latest data from the Hong Kong Stock Exchange shows that on November 19, non-executive director Guo Huaqing increased his holding of Geji Pharmaceutical-B (02171.HK) by 36,500 shares, with a price of HK$17.29 per share, totaling approximately HK$631,100. After the increase, the latest number of shares held is approximately 218.2 million shares, with a shareholding ratio of 37.75%.